未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Fisher, Julie G.; Tait, David; Garrett-Mayer, Elizabeth; Halabi, Susan; Mangat, Pam K.; Schink, Julian C.; Alvarez, Ricardo H.; Veljovich, Dan; Cannon, Timothy L.; Crilley, Pamela A.; Pollock, Theodore; Calfa, Carmen J.; Al Baghdadi, Tareq; Thota, Ramya; Fleming, Nicole; Cotta, Jared A.; Rygiel, Andrew L.; Warren, Sasha L.; Schilsky, Richard L.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏HOXA4 and HOXB3 gene expression signature as a biomarker of tumor recurrence in patients with high-grade serous ovarian cancer (HGSOC) following primary cytoreductive surgery and first-line adjuvant chemotherapy
Patel, Jai N.; Miller, Katherine; Symanowski, James; Sehouli, Jalid; Michener, Chad; Braicu, Ioana; Destephanis, Darla; Sutker, Ashley P.; Norris, Eric J.; Tait, David; Jones, Wendell; Zhang, Qing; Livasy, Chad; Biscotti, Charles; Ganapathi, Ram N.; Ganapathi, Mahrukh K.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏A patient with 17 primary tumours and a germ line mutation in TP53:: Tumour induction by adjuvant therapy?
Nutting, C; Camplejohn, RS; Gilchrist, R; Tait, D; Blake, P; Knee, G; Yao, WQ; Ross, G; Fisher, C; Eeles, R
分享
收藏